Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Effects of Intradialytic Exercise as Assessed by Bioimpedance Analysis and Blood Volume Monitoring
Using Bioimpedance Analysis and Blood Volume Monitoring to Assess the Impact of Intradialytic Exercise
Status: Enrolling
Updated:  1/7/2011
University of Michigan Health System
mi
from
Ann Arbor, MI
Effects of Intradialytic Exercise as Assessed by Bioimpedance Analysis and Blood Volume Monitoring
Using Bioimpedance Analysis and Blood Volume Monitoring to Assess the Impact of Intradialytic Exercise
Status: Enrolling
Updated: 1/7/2011
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Sleep Disturbances as a Risk Factor in Chronic Kidney Disease
Sleep Disturbance as a Non-Traditional Risk Factor in CKD
Status: Enrolling
Updated:  1/27/2011
University of Chicago
mi
from
Chicago, IL
Sleep Disturbances as a Risk Factor in Chronic Kidney Disease
Sleep Disturbance as a Non-Traditional Risk Factor in CKD
Status: Enrolling
Updated: 1/27/2011
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy of Lanthanum Carbonate in Calciphylaxis
Evaluation of Efficacy of Lanthanum Carbonate (Fosrenol) in Patients With Calciphylaxis
Status: Enrolling
Updated:  2/3/2011
University of Wisconsin Hospitals
mi
from
Madison, WI
Efficacy of Lanthanum Carbonate in Calciphylaxis
Evaluation of Efficacy of Lanthanum Carbonate (Fosrenol) in Patients With Calciphylaxis
Status: Enrolling
Updated: 2/3/2011
University of Wisconsin Hospitals
mi
from
Madison, WI
Click here to add this to my saved trials
The Impact of Delflex on Mesothelial Cell Viability and Peritoneal Transport
The Impact of a Biocompatible Peritoneal Dialysis Solution (Delflex Neutral pH)on Mesothelial Cell Viability and Peritoneal Transport
Status: Enrolling
Updated:  2/8/2011
Univ of North Carolina
mi
from
Chapel Hill, NC
The Impact of Delflex on Mesothelial Cell Viability and Peritoneal Transport
The Impact of a Biocompatible Peritoneal Dialysis Solution (Delflex Neutral pH)on Mesothelial Cell Viability and Peritoneal Transport
Status: Enrolling
Updated: 2/8/2011
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Pharmacokinetic Profile of Myfortic (Enteric Coated Mycophenolate Sodium) in a Rapid Steroid Withdrawal Protocol
Pharmacokinetic Profile of Myfortic (Enteric Coated Mycophenolate Sodium) in a Rapid Steroid Withdrawal Protocol in Combination With Tacrolimus in Stable Renal Transplant Recipients in the Fed and Fasting State
Status: Enrolling
Updated:  3/10/2011
University of Utah
mi
from
Salt Lake City, UT
Pharmacokinetic Profile of Myfortic (Enteric Coated Mycophenolate Sodium) in a Rapid Steroid Withdrawal Protocol
Pharmacokinetic Profile of Myfortic (Enteric Coated Mycophenolate Sodium) in a Rapid Steroid Withdrawal Protocol in Combination With Tacrolimus in Stable Renal Transplant Recipients in the Fed and Fasting State
Status: Enrolling
Updated: 3/10/2011
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression
Status: Enrolling
Updated:  5/9/2011
Pediatric Nephrology of Alabama
mi
from
Birmingham, AL
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression
Status: Enrolling
Updated: 5/9/2011
Pediatric Nephrology of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression
Status: Enrolling
Updated:  5/9/2011
UCLA
mi
from
Los Angeles, CA
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression
Status: Enrolling
Updated: 5/9/2011
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression
Status: Enrolling
Updated:  5/9/2011
Stanford University
mi
from
Stanford, CA
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression
Status: Enrolling
Updated: 5/9/2011
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression
Status: Enrolling
Updated:  5/9/2011
Emory University
mi
from
Atlanta, GA
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Novel Pilot Trial of Sirolimus, Mycophenolate Mofetil, and Corticosteroids Versus a Historic Control Population Receiving Calcineurin Inhibitors Based Immunosuppression
Status: Enrolling
Updated: 5/9/2011
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
More Frequent In-Center Hemodialysis in Pediatric End Stage Renal Disease
A Pilot Study of More Frequent In-Center Hemodialysis to Improve Outcomes in Pediatric End Stage Renal Disease
Status: Enrolling
Updated:  5/10/2011
Cincinnati Childrens Hospital Medical Center
mi
from
Cincinnati, OH
More Frequent In-Center Hemodialysis in Pediatric End Stage Renal Disease
A Pilot Study of More Frequent In-Center Hemodialysis to Improve Outcomes in Pediatric End Stage Renal Disease
Status: Enrolling
Updated: 5/10/2011
Cincinnati Childrens Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Impact of Vitamin D Therapies on Chronic Kidney Disease
Impact of Vitamin D Therapies on Monocyte Function in Chronic Kidney Disease
Status: Enrolling
Updated:  5/23/2011
University of Kansas Medical Center
mi
from
Kansas City, KA
Impact of Vitamin D Therapies on Chronic Kidney Disease
Impact of Vitamin D Therapies on Monocyte Function in Chronic Kidney Disease
Status: Enrolling
Updated: 5/23/2011
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
Status: Enrolling
Updated:  6/2/2011
staten island University Hospital nephrology clinic
mi
from
Staten Island, NY
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
Prevalence of Aspirin Resistance in Chronic Kidney Disease Patients
Status: Enrolling
Updated: 6/2/2011
staten island University Hospital nephrology clinic
mi
from
Staten Island, NY
Click here to add this to my saved trials
Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
Pharmacokinetic Study of Propranolol, Losartan, and Eprosartan in Healthy Volunteers and Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  6/6/2011
Clinical Reserach Center, UCSF
mi
from
San Francisco,, CA
Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers
Pharmacokinetic Study of Propranolol, Losartan, and Eprosartan in Healthy Volunteers and Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 6/6/2011
Clinical Reserach Center, UCSF
mi
from
San Francisco,, CA
Click here to add this to my saved trials
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated:  6/7/2011
Transplant Center, University of Minnesota Medical School
mi
from
Minneapolis, MN
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated: 6/7/2011
Transplant Center, University of Minnesota Medical School
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated:  6/7/2011
Division of Transplantation, Drexel University College of Medicine
mi
from
Philadelphia, PA
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated: 6/7/2011
Division of Transplantation, Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated:  6/7/2011
Service de Nephrologie et Transplantation, Hopital Lapeyronie, Centre Hospitalier Universitaire Montpellier
mi
from
Montpellier,
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated: 6/7/2011
Service de Nephrologie et Transplantation, Hopital Lapeyronie, Centre Hospitalier Universitaire Montpellier
mi
from
Montpellier,
Click here to add this to my saved trials
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
The Effect of Sevelamer Carbonate on Critical Variables in the Pathogenesis of Secondary Hyperparathyroidism
Status: Enrolling
Updated:  6/17/2011
Stratton Veterans Affairs Medical Center
mi
from
Albany, NY
Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease
The Effect of Sevelamer Carbonate on Critical Variables in the Pathogenesis of Secondary Hyperparathyroidism
Status: Enrolling
Updated: 6/17/2011
Stratton Veterans Affairs Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure
Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure
Status: Enrolling
Updated:  6/21/2011
Cleveland Clinic
mi
from
Cleveland, OH
Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure
Sequential Cystatin C Levels and Renal Impairment in Acute Heart Failure
Status: Enrolling
Updated: 6/21/2011
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Risk Based Approach to Improving Chronic Kidney Disease Management
A Risk Based Approach to Improving Chronic Kidney Disease Management
Status: Enrolling
Updated:  6/22/2011
Harvard Vanguard Medical Associates
mi
from
Boston, MA
A Risk Based Approach to Improving Chronic Kidney Disease Management
A Risk Based Approach to Improving Chronic Kidney Disease Management
Status: Enrolling
Updated: 6/22/2011
Harvard Vanguard Medical Associates
mi
from
Boston, MA
Click here to add this to my saved trials
Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease
Self-management of Type 2 Diabetes and Chronic Kidney Disease
Status: Enrolling
Updated:  7/19/2011
University of Colorado Hospital
mi
from
Denver, CO
Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease
Self-management of Type 2 Diabetes and Chronic Kidney Disease
Status: Enrolling
Updated: 7/19/2011
University of Colorado Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease
Self-management of Type 2 Diabetes and Chronic Kidney Disease
Status: Enrolling
Updated:  7/19/2011
VA Eastern Colorado Hospital
mi
from
Denver, CO
Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease
Self-management of Type 2 Diabetes and Chronic Kidney Disease
Status: Enrolling
Updated: 7/19/2011
VA Eastern Colorado Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients
The Effect of Short-term Aerobic Training on Arterial Stiffness and Blood in Chronic Kidney Disease (CKD) Patients
Status: Enrolling
Updated:  7/20/2011
Athletic Training and Exercise Science Building
mi
from
Springfield, MA
Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients
The Effect of Short-term Aerobic Training on Arterial Stiffness and Blood in Chronic Kidney Disease (CKD) Patients
Status: Enrolling
Updated: 7/20/2011
Athletic Training and Exercise Science Building
mi
from
Springfield, MA
Click here to add this to my saved trials
Comparison of Markers of Kidney Function
Comparison of Estimated GFR Using Cystatin C Versus Creatinine in Pediatric Renal Transplant Patients
Status: Enrolling
Updated:  7/26/2011
University of California at Los Angeles
mi
from
Los Angeles, CA
Comparison of Markers of Kidney Function
Comparison of Estimated GFR Using Cystatin C Versus Creatinine in Pediatric Renal Transplant Patients
Status: Enrolling
Updated: 7/26/2011
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prospective Donor Specific Antibody (DSA) Monitoring Protocol
Prospective Donor Specific Antibody (DSA) Monitoring Protocol To Detect Patient Characteristics and /or Changes In Immunosuppression on the Development of De Novo Antibodies
Status: Enrolling
Updated:  8/2/2011
Providence Sacred Heart Medical Center
mi
from
Spokane, WA
Prospective Donor Specific Antibody (DSA) Monitoring Protocol
Prospective Donor Specific Antibody (DSA) Monitoring Protocol To Detect Patient Characteristics and /or Changes In Immunosuppression on the Development of De Novo Antibodies
Status: Enrolling
Updated: 8/2/2011
Providence Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"
Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction
Status: Enrolling
Updated:  8/10/2011
Duke Univ Med Ctr
mi
from
Durham, NC
"Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction"
Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction
Status: Enrolling
Updated: 8/10/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
New Needle for Two-Needle Hemodialysis
New Needle for Two-Needle Hemodialysis
Status: Enrolling
Updated:  8/12/2011
DaVita K Street Dialysis Center
mi
from
Washington,
New Needle for Two-Needle Hemodialysis
New Needle for Two-Needle Hemodialysis
Status: Enrolling
Updated: 8/12/2011
DaVita K Street Dialysis Center
mi
from
Washington,
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
University of Colorado Denver
mi
from
Aurora, CO
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
University of Kentucky
mi
from
Lexington, KY
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
University of Michigan
mi
from
Ann Arbor, MI
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
St. Barnabas Medical Center
mi
from
Livingston, NJ
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
St. Barnabas Medical Center
mi
from
Livingston, NJ
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
Montefiore Medical Center
mi
from
Bronx, NY
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
Buffalo General Hospital
mi
from
Buffalo, NY
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
Buffalo General Hospital
mi
from
Buffalo, NY
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
Medical University of South Carolina
mi
from
Charleston, SC
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
Baylor University Medical Center
mi
from
Dallas, TX
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
Baylor University Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
Baylor All Saints
mi
from
Fort Worth, TX
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
Baylor All Saints
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
University of Utah
mi
from
Salt Lake City, UT
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated:  9/21/2011
University of Virginia Health System
mi
from
Charlottesville, VA
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
A Two Part, Phase 1/2, Safety, PK and PD Study of TOL101, an Anti-TCR Monoclonal Antibody for Prophylaxis of Acute Organ Rejection in Patients Receiving Renal Transplantation
Status: Enrolling
Updated: 9/21/2011
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Status: Enrolling
Updated:  10/11/2011
Georgetown University Hospital
mi
from
Washington,
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Status: Enrolling
Updated: 10/11/2011
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
Effects of Active Form of Vitamin D on Renal Blood Flow, Glomerular Filtration Rate, Proteinuria and Inflammation in Patients With Chronic Kidney Disease and Hyperparathyroidism
Status: Enrolling
Updated:  1/10/2012
University of Virginia
mi
from
Charlottesville, VA
Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease
Effects of Active Form of Vitamin D on Renal Blood Flow, Glomerular Filtration Rate, Proteinuria and Inflammation in Patients With Chronic Kidney Disease and Hyperparathyroidism
Status: Enrolling
Updated: 1/10/2012
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and Volume
The Fenofibrate And Microvascular Event Eye (FAME 1 EYE) Trial: A Randomised Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Daily Oral Fenofibrate Compared With Placebo on Macular Thickness and Volume
Status: Enrolling
Updated:  1/15/2012
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
A Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Fenofibrate Versus Placebo on Macular Thickness and Volume
The Fenofibrate And Microvascular Event Eye (FAME 1 EYE) Trial: A Randomised Trial in Adults With Type 1 Diabetes Mellitus Evaluating the Effects of Daily Oral Fenofibrate Compared With Placebo on Macular Thickness and Volume
Status: Enrolling
Updated: 1/15/2012
Oklahoma University Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae
Vital Access Venous Window Needle Guide for Salvage of AV FistulaE (SAVE) Trial
Status: Enrolling
Updated:  1/26/2012
Ladenheim Dialysis Access Centers
mi
from
Fresno, CA
Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae
Vital Access Venous Window Needle Guide for Salvage of AV FistulaE (SAVE) Trial
Status: Enrolling
Updated: 1/26/2012
Ladenheim Dialysis Access Centers
mi
from
Fresno, CA
Click here to add this to my saved trials
Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae
Vital Access Venous Window Needle Guide for Salvage of AV FistulaE (SAVE) Trial
Status: Enrolling
Updated:  1/26/2012
University of Oklahoma - Tulsa
mi
from
Tulsa, OK
Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae
Vital Access Venous Window Needle Guide for Salvage of AV FistulaE (SAVE) Trial
Status: Enrolling
Updated: 1/26/2012
University of Oklahoma - Tulsa
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Multi-Center, Open-Label Study
A Phase I, Multi-Center, Open-Label Study to Examine the Pharmacokinetics of a Single Dose of Droxidopa in Subjects With Renal Impairment Compared to Healthy Volunteers
Status: Enrolling
Updated:  3/7/2012
NOCCR
mi
from
Knoxville, TN
A Multi-Center, Open-Label Study
A Phase I, Multi-Center, Open-Label Study to Examine the Pharmacokinetics of a Single Dose of Droxidopa in Subjects With Renal Impairment Compared to Healthy Volunteers
Status: Enrolling
Updated: 3/7/2012
NOCCR
mi
from
Knoxville, TN
Click here to add this to my saved trials
Pomegranate and Hemodialysis Pilot Trial
A Pilot Trial Assessing the Effect of Pomegranate Juice and Extract on Biomarkers of Oxidative Stress, Systemic Inflammation, and Monocyte Function in Hemodialysis Patients
Status: Enrolling
Updated:  3/22/2012
Northwest Kidney Centers
mi
from
Seattle, WA
Pomegranate and Hemodialysis Pilot Trial
A Pilot Trial Assessing the Effect of Pomegranate Juice and Extract on Biomarkers of Oxidative Stress, Systemic Inflammation, and Monocyte Function in Hemodialysis Patients
Status: Enrolling
Updated: 3/22/2012
Northwest Kidney Centers
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Agave Clinical Research
mi
from
Tempe, AZ
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Agave Clinical Research
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Harrisburg Family Medical Center
mi
from
Harrisburg, AR
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Harrisburg Family Medical Center
mi
from
Harrisburg, AR
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Arkansas Primary Care Clinic, P.A.
mi
from
Little Rock, AR
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Arkansas Primary Care Clinic, P.A.
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Providence Clinical Research
mi
from
San Fernando Valley, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Providence Clinical Research
mi
from
San Fernando Valley, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Sc Clinical Research, Inc.
mi
from
Garden Grove, CA
Click here to add this to my saved trials